Diabetic neuropathy.
Many factors contribute to the nerve damage of diabetes--metabolic (myo-inositol), microvascular, glycosylation and ageing. The variety of clinical syndromes indicates the complexity of the disease. Measurement of peripheral and autonomic nerve function is improving allowing the establishment of prospective natural history and therapeutic studies. There is a need for standardization of clinical definition and staging.
Ward
J D
JD
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D001342:Autonomic Nervous System Diseases / Q000503:physiopathology; D002196:Capillaries; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D010525:Peripheral Nerves / Q000503:physiopathology; D051381:Rats; D014652:Vascular Diseases / Q000150:complications
D000449:Aldehyde Reductase